ARLINGTON, Va., Oct. 19 /PRNewswire/ -- The connection between tattoos and hepatitis C virus (HCV) has long been suspected but never completely substantiated. Tattoos and the connection to the disease were clouded by a perceived propensity to other risk factors, such as injection drug use. "Other studies did not exclude patients with other risk factors for hepatitis C," explains principal investigator Dr. Edmund Bini, "which made it difficult to assess the association between HCV and tattoos. The strength of that association surprised us."
Researchers in New York studied 3871 people, approximately half of whom were control subjects. Patients with HCV were more likely to have had one or more tattoos, and this remained so even after adjusting for age, sex and race/ethnicity.
Patients with tattoos but also with traditional risk factors for HCV -- injection drug use and drug transfusion prior to 1992 -- were excluded from the final analysis of the data of the remaining 1887 patients with tattoos and no other risk factors for HCV, patients with HCV were approximately three times more likely to have had tattoos. This connection was significant even after, once again, adjusting for age, sex, and race/ethnicity.
The researchers concluded that all patients with tattoos should be tested for HCV. "It helps to be able to identify patients early who are eligible for treatment," said Dr. Bini. This information will be further refined when they complete analysis of assessing the risk of having multiple tattoos, as well as whether the patient received the tattoo in the US or abroad.
Strong association between tattoos and hepatitis C virus infection: A multicenter study of 3,871 patients
AASLD is the leading medical organization for advancing the science and practice of hepatology. Founded by physicians in 1950, AASLD's vision is to prevent and cure liver diseases. This year's Liver Meeting, held in Boston, Massachusetts November 2-6, will bring together almost 5,000 researchers from 55 countries.
A pressroom will be available from November 3 at the annual meeting. Abstract and press release copies, or to arrange for pre-conference research interviews, contact Gregory Bologna, 703-299-9766. To pre-register, call Ann Tracy, 703-299-9766.
Press releases and abstracts available online at http://www.aasld.org.
This release was issued through The Xpress Press News Service, merging e- mail and satellite distribution technologies to reach business analysts and media outlets worldwide. For more information, visit http://www.XpressPress.com
|SOURCE American Association for the Study of Liver Diseases|
Copyright©2007 PR Newswire.
All rights reserved